Connection

MELINDA YATES to Liver

This is a "connection" page, showing publications MELINDA YATES has written about Liver.
Connection Strength

0.256
  1. Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice. Carcinogenesis. 2009 Jun; 30(6):1024-31.
    View in: PubMed
    Score: 0.163
  2. Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes. Mol Cancer Ther. 2007 Jan; 6(1):154-62.
    View in: PubMed
    Score: 0.035
  3. Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole. Cancer Res. 2006 Feb 15; 66(4):2488-94.
    View in: PubMed
    Score: 0.033
  4. Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide. Eur J Pharmacol. 2009 Oct 12; 620(1-3):138-44.
    View in: PubMed
    Score: 0.010
  5. Genetic or pharmacologic amplification of nrf2 signaling inhibits acute inflammatory liver injury in mice. Toxicol Sci. 2008 Jul; 104(1):218-27.
    View in: PubMed
    Score: 0.009
  6. Formation of fibrinogen-based hydrogels using phototriggerable diplasmalogen liposomes. Bioconjug Chem. 2002 May-Jun; 13(3):640-6.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.